Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
AstraZeneca ( (GB:AZN) ) has shared an update.
The Capital Group Companies, Inc., a major investment management company based in Los Angeles, has acquired a significant stake in AstraZeneca PLC, crossing a 5% threshold of voting rights on January 29, 2025. This acquisition highlights Capital Group’s strategic interest in AstraZeneca’s operations, potentially influencing the company’s future governance and strategic decisions.
More about AstraZeneca
AstraZeneca is a UK-based global pharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in areas such as oncology, cardiovascular, renal, and metabolism, as well as respiratory and immunology.
YTD Price Performance: 11.90%
Average Trading Volume: 2,726,647
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £181.6B
Learn more about AZN stock on TipRanks’ Stock Analysis page.
